Economic burden of microscopic colitis in relation to disease activity: a nationwide cost-of-illness study
Compared with the general population, patients with MC had almost twice as high annual mean costs. Excess costs were particularly high in patients with a high disease activity at onset, mainly driven by work loss.
Authors
- Hamed Khalili (ORCID: https://orcid.org/0000-0002-7956-6941)
- Anne F. Peery (ORCID: https://orcid.org/0000-0002-2005-0780)
- Karl Mårild (ORCID: https://orcid.org/0000-0003-2285-8713)
- Martin Neovius (ORCID: https://orcid.org/0000-0003-2300-3055)
- Soran Rabin Bozorg (ORCID: https://orcid.org/0000-0003-2862-8855)
- Asa Hallqvist Everhov (ORCID: https://orcid.org/0000-0002-0311-8894)
- Jonas Filip Ludvigsson (ORCID: https://orcid.org/0000-0003-1024-5602)
- David Bergman (ORCID: https://orcid.org/0000-0002-4323-0266)
Institutions
- University of North Carolina at Chapel Hill (US)
- National Academy of Medicine (US)
- Karolinska University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Massachusetts General Hospital (US)
- Drottning Silvias barn- och ungdomssjukhus (SE)
- Örebro University Hospital (SE)
- Columbia College (CA)
- Institute for Medical Informatics and Biostatistics (CH)
- Columbia University (US)
- University of Gothenburg (SE)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf204
- Citations
- 1
- Primary Topic
- Microscopic Colitis
- Type
- article
- Field-Weighted Citation Impact
- 1.35